Alpine Global Management, LLC Celldex Therapeutics, Inc. Transaction History

Alpine Global Management, LLC

  • $331 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$27.64 - $39.32 $438,923 - $624,401
-15,880 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$35.68 - $56.27 $566,598 - $893,567
15,880 New
15,880 $614,000
Q1 2021

May 13, 2021
SELL
$16.19 - $29.91 $482,785 - $891,916
-29,820 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$14.99 - $22.75 $447,001 - $678,405
29,820 New
29,820 $522,000

Others Institutions Holding CLDX

# of Institutions
207
Shares Held
67.3M
Call Options Held
1.69M
Put Options Held
980K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.3B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Alpine Global Management, LLC Portfolio

Follow Alpine Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email